Ephedrine and its alkaloids are used for the treatment of asthma, nasal con
gestion, and obesity. Ephedrine, with two chiral centers, exists as four is
omers that exhibit direct and indirect effects on both alpha- and beta-adre
nergic receptors (AR). Our main goal was to study the direct effects of the
ephedrine isomers on human beta(1)-, beta(2)-, and beta(3)-AR expressed in
Chinese hamster ovary cells. Previous work indicated that the ephedrine is
omers are inactive as agonists and that 1R,2S-ephedrine is more potent than
the 1S,2R-isomer as an antagonist of catecholamine-induced lipolysis in ra
t adipose tissue (Lee et al., J Pharmacol Exp Ther 190: 249-259, 1974). Sti
mulation of adenylyl cyclase, associated with cyclic AMP accumulations, was
measured by a luciferase reporter gene assay. On human beta(1)-AR, the ran
k order of potency (EC50 values, maximal response relative to isoproterenol
= 100%) was 1R,2S-ephedrine (0.5 mu M, 68%) > 1S,2R ephedrine (72 mu M, 66
%) > 1S,2S-pseudoephedrine (309 mu M, 53%) = 1R,2R-pseudoephedrine (1122 mu
M, 53%). On human beta(2)-AR, the rank order of potency was 1R,2S-ephedrin
e (0.36 mu M, 18%) > 1R,2R-pseudoephedrine (7 mu M, 50%) greater than or eq
ual to 1S,2S-pseudoephedrine (10 mu M, 47%) > 1S,2R-ephedrine (106 mu M, 22
%). Only 1R,2S-ephedrine showed significant agonist activity on human beta(
3)-AR with an EC50 = 45 mu M and a maximal response of 31%. Our studies dem
onstrated that (a) stereoselective and rank order differences exist among t
he direct effects of ephedrine isomers; (b) 1R,2S-ephedrine is the most pot
ent of the four ephedrine isomers on all three human beta-AR; and (c) 1R,2S
- ephedrine was nearly equipotent as a beta(1)-/beta(2)-AR agonist and the
only isomer possessing weak partial agonist activity on beta(3)-AR. (C) 199
9 Elsevier Science Inc.